跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 良宗
教授
,
微生物免疫學科
合聘教授
,
全球衛生暨衛生安全碩士學位學程
合聘教授
,
全球衛生暨衛生安全博士學位學程
合聘教授
,
細胞治療與再生醫學國際博士學位學程
https://orcid.org/0000-0001-7374-7234
電子郵件
ltlin
tmu.edu
tw
h-index
7659
引文
37
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2002
2024
每年研究成果
概覽
指紋
網路
專案
(25)
研究成果
(98)
資料集
(1)
類似的個人檔案
(6)
指紋
查看啟用 Liang Tzung Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
100%
Hepatitis C Virus
89%
Infection
84%
Liver Cell Carcinoma
82%
Malignant Neoplasm
79%
Nanoparticle
65%
Disease
39%
Measles Virus
39%
Antioxidant
39%
Virus Infection
38%
Hepatitis C
34%
Breast Cancer
31%
Dengue Virus
31%
Antiviral Activity
31%
Mouse
28%
Single Chain Fragment Variable Antibody
27%
Neoplasm
26%
Chebulagic Acid
25%
Human Alphaherpesvirus 1
25%
Antioxidant Capacity
24%
Cuscuta Chinensis
23%
Cinnamaldehyde
23%
Traditional Chinese Medicine
22%
Cytotoxicity
22%
Immunoglobulin Y
20%
Coronavirinae
19%
Enzyme-Linked Immunosorbent Assay
18%
Tannin Derivative
18%
Ebola Virus
18%
IC50
17%
Immunotherapy
17%
Breast Adenocarcinoma
17%
Artocarpus
17%
Mitogen Activated Protein Kinase
17%
Hepatotoxicity
16%
Liver Cancer
16%
Doxorubicin
15%
Coxsackievirus A16
15%
Colorectal Cancer
15%
Paris polyphylla
15%
Glycosaminoglycan
15%
Gallic Acid
15%
Euphorbia
15%
Phyllanthus
15%
Paracetamol
15%
Triterpene
15%
Herpes Simplex Virus 2
15%
Ursolic Acid
15%
Silymarin
15%
SARS Coronavirus
15%
Immunology and Microbiology
Hepatitis C Virus
86%
Viral Entry
76%
Single-Chain Variable Fragment
51%
Viral Disease
41%
Measles Virus
39%
Vaccine Efficacy
34%
Dengue Virus
33%
Glycoprotein
27%
Cancer Cell
27%
Immunoglobulin Y
22%
Nectin
21%
Host Cell
20%
Cell Death
19%
Hepatitis C
19%
Antiviral Activity
19%
Viral Replication
19%
Mouse
18%
Blood Plasma
18%
Monospecific Antibody
18%
Microglia
18%
Immunotherapy
17%
Surface Property
17%
Autophagy
17%
Hepacivirus
15%
Coxsackievirus A16
15%
Cell Migration
15%
Endogenous Retrovirus
15%
Bungarus
15%
Neutralizing Antibody
15%
Virus Attachment
14%
Virus Infectivity
14%
Cell Surface
13%
Molecular Docking
13%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Virus Particle
13%
Innate Immune System
12%
Replicon
12%
Human Alphaherpesvirus 1
11%
COVID-19
11%
Retrovirus
10%
Human Immunodeficiency Virus
10%
Zika Virus
10%
Venom Antiserum
10%
Tumor Cell
10%
Virus Hemagglutinin
9%
Ebola Virus
9%
Membrane Fusion
9%
Wild Type
9%
Enzyme-Linked Immunosorbent Assay
9%
Flaviviridae
8%
Medicine and Dentistry
Cancer Cell
30%
Malignant Neoplasm
28%
Virus Infection
21%
COVID-19
19%
Cell Migration
18%
Virus Entry
18%
Microglia
17%
Antivirus Agent
16%
Infection
16%
Dengue Virus
15%
Programmed Cell Death
15%
Cell Cycle Arrest
15%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Innate Immunity
11%
Neoplasm
10%
Mitogen-Activated Protein Kinase
9%
Immunotherapy
9%
Cancer Therapy
9%
Tumor Microenvironment
9%
Hepatitis C Virus
9%
Herbal Medicine
8%
Traditional Chinese Medicine
8%
In Vitro
8%
Tumor Progression
7%
Human Immunodeficiency Virus Fusion Inhibitor
7%
Membrane Fusion
7%
Measles Virus
7%
Acetylcholine
7%
Liposome
7%
Rhenium 188
7%
Xiao Chai Hu Tang
7%
Hepatocellular Carcinoma
7%
Ovarian Tumor
7%
Blood Product
7%
Endogenous Retrovirus
7%
Macroautophagy
7%
Fusobacterium nucleatum
7%
Daisaikoto
7%
Colorectal Cancer
7%
Ovarian Cancer
7%
Treatment of Parkinson's Disease
7%
Glucose Uptake
7%
Insulin Signaling
7%
Disease Course
7%
Natural Product
7%
Diabetic Nephropathy
7%
Retroviridae
7%
Diabetes Mellitus
7%
Benzamide
7%
Virus Encephalitis
7%
